Steris (FRA:2TG) Tariff Resilience Score: 7/10 (As of Jul. 09, 2026)


FRA:2TG Steris PLC FRA:2TG
85 GF Score
Price €183.20
GF Value €235.65
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Steris Tariff Resilience Score?

Steris FRA:2TG +3.44% 85 Tariff Resilience Score is 7 as of Jul. 09, 2026. GuruFocus rates FRA:2TG with a GF Score™ of 85/100 and a GF Value™ of €235.65 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 835 Medical Devices & Instruments companies, Steris ranks better than 98.08% on this metric.

Steris has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Steris has Steris PLC, a medical equipment company, has a global supply chain but benefits from strong pricing power and diversified manufacturing locations. Its ability to navigate previous tariff changes supports its resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Steris might have Highly Resilient.

Steris  (FRA:2TG) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Steris Tariff Resilience Score Related Terms

FRA:2TG vs ZBH, DXCM, PEN: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Steris's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steris Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Steris's Tariff Resilience Score falls into.


FRA:2TG
85GF Score
Steris PLC FRA:2TG
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Steris (FRA:2TG) has a Tariff Resilience Score of 7 as of Jul. 09, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Steris ranks #16 out of 835 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is Steris' Tariff Resilience Score too high?
Steris' current Tariff Resilience Score is 7. Based on the distribution chart, Steris ranks #16 out of 835 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Steris has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Steris' Tariff Resilience Score compare to ZBH and DXCM?
According to the Medical Devices & Instruments industry distribution chart, Steris ranks #16 out of 835 companies for Tariff Resilience Score. This places Steris in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Steris's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Based on GuruFocus' analysis, Steris (FRA:2TG) is currently considered Modestly Undervalued. The stock's GF Value™ is €235.65, compared to a current price of €183.20 — trading 22.3% below its estimated fair value. The current Tariff Resilience Score is 7. Steris' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Steris (FRA:2TG), the current Tariff Resilience Score is 7 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (FRA:2TG) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of €183.20 is trading 22.3% below its estimated GF Value™ of €235.65. GuruFocus considers Steris to be Modestly Undervalued.

Key valuation signals for FRA:2TG:

  • Tariff Resilience Score: 7
  • GF Value™: €235.65 vs. price of €183.20 (22.3% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the FRA:2TG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Steris Business Description

Other Exchanges STE:USAS1TE34:Brazil
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
85GF Score

Get the complete analysis for FRA:2TG

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€183.20
Price
€235.65
GF Value